| Literature DB >> 23688355 |
Michael Wayne1, Deniz Gur, Gil Ascunce, Ben Abodessa, Violette Ghali.
Abstract
We report a case of mucinous cystic neoplasm of pancreas with sarcomatous stroma metastasizing to the liver. The tumor occurred in a male patient aged 46 years. Symptoms included persistent epigastric and right upper quadrant pain. Radiographically, the pancreas contained four large cystic masses located in the neck, body, and tail. Histologically, the cysts were lined with benign, mucinous epithelium with underlying bland, storiform, ovarian-like stroma. An undifferentiated focally hyalinized, sarcomatous stroma composed of bland spindle cells showing short fascicular growth pattern and focal nuclear palisading was associated with the epithelial component in one of the cysts. These cells showed strong immunoreactivity with vimentin and inhibin (weak), they were negative for CD34, estrogen receptor, progesterone receptor, androgen, calretinin, S-100, CD117, melan A, chromogranin, and synaptophysin. A morphologically and immunohistochemically identical metastatic sarcomatous focus was identified in the liver without any glandular component. This case is unique in its clinically malignant behaviour and metastatic nature despite its morphologically benign epithelial and stromal components.Entities:
Mesh:
Year: 2013 PMID: 23688355 PMCID: PMC3664077 DOI: 10.1186/1477-7819-11-100
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Figure 1Endoscopic ultrasonography and computed tomography. A-B) Endoscopic ulrasonography showing cysts in neck, body and tail of Pancreas. C) Computed tomography of pancreas showing cystic mass with hemorrhage.
Figure 2Pictures of pancreatic cysts, cyst lined by benign mucinous epithelium, sarcomatous stroma in pancreas, and sarcomatoid metastatic foci in liver. (A) Gross picture of pancreatic cysts occupying neck, body and tail. (B) Cyst lined by benign mucinous epithelium with underlying ovarian-like, storiform stroma (H & E, 10×) (C) Sarcomatous stroma in pancreas. Spindle stromal cells with fascicular growth pattern and nuclear palisading. Focal areas of dense, acellular, hyalinized tissue are evident (H & E, 20×) (D) Sarcomatoid metastatic foci in liver. Morphology is identical to lesion in pancreas (H & E, 20×).
Figure 3Immunohistochemical studies. (A) Epithelial component of the lesion is CAM5.2 positive. Sarcomatous stroma shows strong vimentin (B) and weak inhibin (C) immunoreactivity. (D) Sarcomatous component has a low Ki67 index (1% to 3%).
Summary of reported cases of mucinous cystic neoplasm of pancreas with sarcomatous component
| [ | 48 | M | MCN, carcinosarcoma | Pleomorphism, high-grade atypia, atypical mitosis, necrosis | Vimentin (+) |
| ER, PR (−) | |||||
| Liver and lymph node metastasis of carcinoma | S100 (−) | ||||
| CD34 (−) | |||||
| SMA (−) | |||||
| [ | 70 | F | MCN, invasive adenocarcinoma | Spindle cell sarcoma | Vimentin (+) |
| Mucin 1 (+) | |||||
| [ | 67 | F | MCN, invasive adenocarcinoma | Pleomorphic sarcoma | Vimentin (+) |
| Moderate to high-grade atypia | S100 (−) | ||||
| Atypical mitosis | c-Kit (−) | ||||
| Metastasis to liver | | ||||
| [ | 30 | F | MCN | MCN with mesenchymal overgrowth | ER, PR (+) |
| Mild atypia, low number of mitoses | |||||
| No metastasis | |||||
| [ | 48 | F | MCN with atypia | MCN with sarcomatous stroma | Vimentin, MSA, SMA |
| ER and PR (+) | |||||
| 66 | F | MCN with atypia | MCN with sarcomatous stroma | Vimentin, | |
| Moderate to high-grade atypia | MSA, SMA, | ||||
| Numerous mitoses | S100 (variable), | ||||
| Distant metastasis | ER and PR (+) | ||||
| 67 | M | MCN, invasive adenocarcinoma | MCN with sarcomatous stroma | Vimentin, | |
| MSA, SMA, | |||||
| Moderate to high-grade atypia | S100 (+) | ||||
| ER and PR (−) | |||||
| Numerous mitoses | |||||
| Omental metastasis | |||||
| [ | 43 | F | MCN | MFH | Vimentin, lysozyme, α1 antitrypsin |
| [ | 45 | F | MCN | Pseudosarcomatous, mural nodules | CK, EMA, Vimentin |
ER, estrogen receptor; MCN, mucinous cystic neoplasm; MFH, malignant fibrous histiocytoma; MSA, muscle-specific actin; PR, progesterone receptor; SMA, smooth muscle actin.